On June 26, 2025, the 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2025) was successfully concluded at the Shanghai New International Expo Center. As an annual event for the global pharmaceutical industry, especially the peptide industry, it has sprung up like mushrooms after rain. This exhibition brought together more than 3,200 world-renowned companies and nearly 300 international leading brands, with an exhibition area of ​​more than 230,000 square meters. The scene was crowded with people and the negotiations were hot, showing the international influence and strong vitality of China's biopharmaceutical industry. Gutuo Biotech brought its core products, such as Somaglutide, Telpotide, Retaglutide, and Akirelin, to the glorious appearance, opening this wonderful exchange journey in the peptide industry.

During the exhibition, the booth of Goutuo Biotech was in an excellent location, attracting the attention of a large number of domestic and foreign customers, partners and peers in the peptide industry. There was an endless stream of people coming to consult and negotiate, and they showed great interest in Goutuo Biotech's products and technologies.

With solid professional knowledge and good communication skills, Goutuo's elites warmly received every visitor, introduced the company's product features, production processes, quality standards and application areas in detail, patiently answered customer questions, and provided personalized solutions according to customer needs, winning high recognition and praise from customers.

Through on-site product introductions, technical explanations and case sharing, customers can have a more intuitive understanding of the advantages and value of GUTUO Biological products.

In addition, the company also actively participated in various peptide forums, seminars and industry exchange activities held during the exhibition, sharing the latest achievements and practical experience of GUTO Biotech in raw material research and development, production technology innovation and quality control, demonstrating GUTO Biotech's pursuit of excellence, and discussing industry development trends, cutting-edge technology applications, and market opportunities and challenges with industry colleagues.

In the future, we will continue to uphold the development concept of "authenticity, focus, efficiency, and innovation", continuously increase R&D investment, improve product quality and innovation capabilities, and further expand domestic and foreign markets. Goutuo Bio will accelerate the internationalization process, work with industry colleagues to explore the path of high-quality development, and contribute to the vigorous development of the global pharmaceutical industry.